Managers / Q3 2021 · view latest →
STARR INTERNATIONAL CO INC
CIK 0001236615 · 101 BAARERSTRASSE, ZUG, V8, CH-6300 · (4141) 768-9797
Summary
Starr International Co Inc reported $50M in U.S.-listed holdings across 5 positions for Q3 2021.
The portfolio is heavily concentrated: MRNA alone accounts for 51.7% of reported value.
The book was largely unchanged from Q2 2021.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.8% · $44M
- ADR · 11.2% · $6M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BCSFBAIN CAPITAL SPECIALTY FINANCE ORD | HELD | +9.7K | 794.5K | −$218,000 | $12M |
| MRNAMODERNA ORD | HELD | +0 | 67.0K | +$10M | $26M |
| AIGAMERICAN INTERNATIONAL GROUP ORD | HELD | +0 | 62.8K | +$457,000 | $3M |
| JNJJOHNSON & JOHNSON ORD | HELD | +0 | 20.0K | −$65,000 | $3M |
| AZNNASTRAZENECA ADR REP 0.5 ORD | HELD | +0 | 93.0K | +$15,000 | $6M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | MRNAMODERNA ORDhistory → | COM | 51.74% | $26M | 67.0K |
| 2 | BCSFBAIN CAPITAL SPECIALTY FINANCE ORDhistory → | COM STK | 23.66% | $12M | 794.5K |
| 3 | AZNNASTRAZENECA ADR REP 0.5 ORDhistory → | SPONSORED ADR | 11.21% | $6M | 93.0K |
| 4 | AIGAMERICAN INTERNATIONAL GROUP ORDhistory → | COM NEW | 6.91% | $3M | 62.8K |
| 5 | JNJJOHNSON & JOHNSON ORDhistory → | COM | 6.48% | $3M | 20.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $20M | 3 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | Under review | 3 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $20,392 | 3 | May 3, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 3 | Feb 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $48M | 3 | Oct 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $66M | 3 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $149M | 3 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $60M | 3 | Jan 27, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $50M | 5 | Nov 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $40M | 5 | Jul 19, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $31M | 5 | Apr 21, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $27M | 5 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $22M | 5 | Oct 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $13M | 3 | Jul 20, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $139M | 33 | Apr 9, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $204M | 29 | Jan 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $228M | 42 | Oct 11, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $240M | 35 | Jul 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $251M | 113 | Apr 30, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $121M | 21 | Feb 1, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.